ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics

ANIP POWR Grades

• ANIP scores best on the Growth dimension, with a Growth rank ahead of 83% of US stocks.
• The strongest trend for ANIP is in Momentum, which has been heading down over the past 47 weeks.
• ANIP ranks lowest in Quality; there it ranks in the 10th percentile.

ANIP Stock Summary

• Price to trailing twelve month operating cash flow for ANIP is currently 26.51, higher than 79.07% of US stocks with positive operating cash flow.
• Of note is the ratio of Ani Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; 25.85% of US stocks have a lower such ratio.
• The volatility of Ani Pharmaceuticals Inc's share price is greater than that of only 17.65% US stocks with at least 200 days of trading history.
• Stocks with similar financial metrics, market capitalization, and price volatility to Ani Pharmaceuticals Inc are VIPS, TTMI, CCMP, EHTH, and DHX.
• ANIP's SEC filings can be seen here. And to visit Ani Pharmaceuticals Inc's official web site, go to www.anipharmaceuticals.com.

ANIP Valuation Summary

• In comparison to the median Healthcare stock, ANIP's EV/EBIT ratio is 285.67% lower, now standing at -54.4.
• Over the past 243 months, ANIP's price/sales ratio has gone NA NA.
• ANIP's price/earnings ratio has moved down 8.8 over the prior 243 months.

Below are key valuation metrics over time for ANIP.

ANIP Growth Metrics

• Its 5 year revenue growth rate is now at 156.46%.
• Its 2 year revenue growth rate is now at 8.96%.
• The 5 year cash and equivalents growth rate now stands at -83.16%.

ANIP's revenue has moved up $21,637,000 over the prior 33 months.

The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	213.377	13.586	-17.221
2021-03-31	213.222	34.225	-15.451
2020-12-31	208.475	15.267	-22.548
2020-09-30	199.189	25.779	-23.748
2020-06-30	197.547	49.186	-20.287
2020-03-31	203.434	33.05	-1.366

ANIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ANIP has a Quality Grade of D, ranking ahead of 10.54% of graded US stocks.
• ANIP's asset turnover comes in at 0.457 -- ranking 99th of 677 Pharmaceutical Products stocks.
• EGRX, NAII, and CBIO are the stocks whose asset turnover ratios are most correlated with ANIP.

The table below shows ANIP's key quality metrics over time.